Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
49 hedge funds and large institutions have $167M invested in Loxo Oncology, Inc in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
17% more funds holding
Funds holding: 42 → 49 (+7)
11% more capital invested
Capital invested by funds: $150M → $167M (+$16.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.41M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$2.18M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.43M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$1.24M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$872K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$1.62M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$810K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$156K |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$20.3K |
| 5 |
BJ
BlackRock Japan
Tokyo,
Japan
|
-$5.49K |
LOXO Hedge Fund Activity: Q1 2015 in Review
49 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2015, worth a combined $167M — up 11% from $150M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new LOXO positions and 2 closed out — a net gain of 7 holders — while 18 added to existing stakes and 7 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.41M. The largest seller was Redmile Group, exiting entirely with an estimated $1.62M sold.
- 49 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2015, up from 42 in Q4 2014.
- Funds reported $167M of Loxo Oncology, Inc stock for Q1 2015, up 11% quarter-over-quarter.
- 9 funds opened new Loxo Oncology, Inc positions in Q1 2015 and 2 closed out, a net change of +7 holders.
- The largest Loxo Oncology, Inc buyer in Q1 2015 was Millennium Management, an estimated $3.41M added.
- The largest Loxo Oncology, Inc seller in Q1 2015 was Redmile Group, an estimated $1.62M sold.
Based on aggregated 13F filings for Q1 2015.